Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque Psoriasis

July 1, 2017

In July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.

Links to PDF